Home
What we do
Our approach
Our products
Our location
Help us
Contact us
Our Products:
MarketVIEW (all vaccines)
MasterVIEW (novel vaccines)
ExpertREACT (newsletter)
Company Brochure:
Summer 2022
Follow @vaczineanalytic
Other Research:
A.baumannii
vaccines forecast
Staphylococcus aureus BSI/SSI vaccines
(USA)
mRNA vaccines - infectious diseases
ExPEC
vaccines forecast
HPV therapeutic
vaccines forecast
Shigella
vaccines forecast
Dengue
vaccines (travelers)
Opioid use disorder
vaccines forecast
Pertussis booster vaccines
Cholera vaccines
Universal influenza vaccines
Zika virus vaccines
HBV vaccines
H. pylori vaccines
More...
Home
VacZine Analytics is a strategic research publisher based in the United Kingdom since 2007.
We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry.
Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.
Join Our Email List
Latest Research
Vaccines/mRNA Strategic Pipeline Review
Aug '22
SAMPLE
Respiratory Syncytial Virus
vaccines/mAb forecast
July '22 New!
Herpes Simplex Virus
vaccines TX forecast
June '22 New!
Herpes Simplex Virus
vaccines PX forecast
June '22 New!
Epstein-Barr virus
vaccines forecast
Mar '22
Congenital Cytomegalovirus
vaccines forecast
Apr '22
Nipah virus
vaccines forecast
Q1 '22
Periodontal disease
vaccines forecast
Q1 '22
Respiratory virus
vaccines segment forecast
Sept '21
Dengue endemic
vaccines forecast
Sept '21
INTERACTIVE
Coronavirus
[COVID-19] vaccines forecast
Order
SAMPLE
Seasonal influenza
vaccines forecast
Jan '21
New vaccine products
USA forecast
Order
Chikungunya
vaccines forecast
Sept '20
Rift Valley Fever
vaccines forecast
July '20
Norovirus
vaccines forecast
June '20
MERS-CoV
vaccines forecast
Jan '20
Lassa fever
vaccines forecast
Nov '19
Lyme Borreliosis
vaccines forecast
June '19
Campylobacter
vaccines forecast
June '19
Latest News
Tweets by VacZineAnalytic
© 2022 VacZine Analytics. All rights reserved.
Disclaimer
|
Privacy
|
Terms and conditions
.
We are an equal opportunities employer.
